Clinical Trial Update: A Study on Using SFRT With Standard Treatment for Oligoprogressive NSCLC [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial investigates SFRT with standard treatment for oligoprogressive non-small cell lung cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: RECRUITING